TB & Outbreaks Week
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of TB & Outbreaks Week
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Hemorrhagic Fever
Findings from Cumhuriyet University, Medical Department provide new insights into hemorrhagic fever
April 29th, 2008
"The aim of this study was to investigate cochlear damage in Crimean-Congo hemorrhagic fever (CCHF) infection. Thirty-two CCHF patients (study group) and 13 healthy people (controls) were included in the study," scientists in Sivas, Turkey report. "CCHF patients were also grouped for the presence of fever. CCHF was diagnosed with the presence of CCHF virus-specific IgM antibody or CCHF virus (CCHFV) antigen by ELISA. Cochlear damage was determined by a 'fail' in the transient evoked otoacoustic emission (TEOAE) test. The proportion of TEOAE test 'fail' results in the CCHF patients was significantly higher than in the control group (p < 0.05). We found no increase in...
Source: TB & Outbreaks Week (2008-04-29)
|
